EASL Studio Podcast Special Edition: Unexplained acute hepatitis in children

EASL Studio S2 E13: Digital Pathology

EASL Studio Podcast S2 E13: Digital Pathology

EASL Studio S2 E12: Nurse and AHP Focus: Sustainable hepatology – Insights in nursing initiatives

EASL Studio Podcast S2 E12: Nurse and AHP Focus: Sustainable hepatology – Insights in nursing initiatives

EASL Studio S2 E11: JHEP Live: Stop Nuc in HBeAg negative patients

EASL Studio Podcast S2 E11: JHEP Live: Stop Nuc in HBeAg negative patients

EASL Studio S2 E10: LITMUS: Defining the colour of NAFLD

EASL Studio Podcast S2 E10: LITMUS: Defining the colour of NAFLD

EASL Studio S2 E9: YI Choice: Propelling liver cell biology into the third dimension

EASL Studio podcast S2 E9: YI Choice: Propelling liver cell biology into the third dimension

EASL Studio S2 E8: Treatment of HBV-HDV coinfection in the era of entry inhibition

EASL Studio Podcast S2 E8: Treatment of HBV-HDV coinfection in the era of entry inhibition

EASL Studio S2 E7: JHEP Live on critical appraisal of classification, diagnosis and treatment of hepatic encephalopathy

EASL Studio Podcast S2 E7: JHEP Live on critical appraisal of classification, diagnosis and treatment of hepatic encephalopathy

EASL Studio S2 E6: Should anticoagulants be given to patients with cirrhosis to improve outcome?

EASL Studio Podcast S2 E6: Should anticoagulants be given to patients with cirrhosis to improve outcome?

EASL Studio S2 E5: New era for science dissemination: The role of social media

EASL Studio Podcast S2 E5: New era for science dissemination: The role of social media

EASL Studio S2 E4: Betablockers in cirrhosis: Has Baveno consensus gone too far?